These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19879152)

  • 1. Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in rats.
    Hadizad T; Kirkpatrick SA; Mason S; Burns K; Beanlands RS; Dasilva JN
    Bioorg Med Chem; 2009 Dec; 17(23):7971-7. PubMed ID: 19879152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of [(11)C]methyl-losartan and [(11)C]methyl-EXP3174 for PET imaging of renal AT1receptor in rats.
    Ismail B; Hadizad T; Antoun R; Lortie M; deKemp RA; Beanlands RS; DaSilva JN
    Nucl Med Biol; 2015 Nov; 42(11):850-7. PubMed ID: 26300209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of the novel 2-[¹⁸F]fluoro-3-propoxy-triazole-pyridine-substituted losartan for imaging AT₁ receptors.
    Arksey N; Hadizad T; Ismail B; Hachem M; Valdivia AC; Beanlands RS; deKemp RA; DaSilva JN
    Bioorg Med Chem; 2014 Aug; 22(15):3931-7. PubMed ID: 25023539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the high affinity [
    Abreu Diaz AM; Drumeva GO; Laporte P; Alonso Martinez LM; Petrenyov DR; Carrier JF; DaSilva JN
    Nucl Med Biol; 2021; 96-97():41-49. PubMed ID: 33798796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
    Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
    Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of [11C]methyl-candesartan kinetics in the rat kidney for the assessment of angiotensin II type 1 receptor density in vivo with PET.
    Lortie M; DaSilva JN; Kirkpatrick SA; Hadizad T; Ismail BA; Beanlands RS; deKemp RA
    Nucl Med Biol; 2013 Feb; 40(2):252-61. PubMed ID: 23352346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder.
    Aikawa K; Sakai T; Ishibashi K; Shiomi H; Sagawa K; Kumagai S; Kataoka M; Akaihata H; Yamaguchi O
    Int J Urol; 2012 May; 19(5):457-64. PubMed ID: 22320898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new carbon-11 labelled radiotracers for imaging GABAA- and GABAB-benzodiazepine receptors.
    Moran MD; Wilson AA; Elmore CS; Parkes J; Ng A; Sadovski O; Graff A; Daskalakis ZJ; Houle S; Chapdelaine MJ; Vasdev N
    Bioorg Med Chem; 2012 Jul; 20(14):4482-8. PubMed ID: 22717238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel O-[
    Teyssier VR; Tournoux F; Simard JM; Gaudette F; Boudjemeline M; Petrenyov DR; DaSilva JN
    Nucl Med Biol; 2021; 102-103():34-44. PubMed ID: 34601168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism.
    Ntountaniotis D; Andreadelis I; Kellici TF; Karageorgos V; Leonis G; Christodoulou E; Kiriakidi S; Becker-Baldus J; Stylos EK; Chatziathanasiadou MV; Chatzigiannis CM; Damalas DE; Aksoydan B; Javornik U; Valsami G; Glaubitz C; Durdagi S; Thomaidis NS; Kolocouris A; Plavec J; Tzakos AG; Liapakis G; Mavromoustakos T
    Mol Pharm; 2019 Mar; 16(3):1255-1271. PubMed ID: 30681344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
    Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
    J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel [
    Alonso Martinez LM; DaSilva JN
    J Labelled Comp Radiopharm; 2021 Mar; 64(3):120-128. PubMed ID: 33084079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
    Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
    Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
    J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
    Fu H; Hosomi N; Pelisch N; Nakano D; Liu G; Ueno M; Miki T; Masugata H; Sueda Y; Itano T; Matsumoto M; Nishiyama A; Kohno M
    J Hypertens; 2011 Nov; 29(11):2210-9. PubMed ID: 21934531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys.
    Yoshioka I; Tsujihata M; Akanae W; Nonomura N; Okuyama A
    Urology; 2011 Apr; 77(4):1007.e9-1007.e14. PubMed ID: 21256551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
    Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
    J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prevention of hypertension and end-organ damage in Ren-2 transgenic rats is achieved only with persistent but not transient AT1 receptor blockade.
    Vanecková I; Kopkan L; Husková Z; Vanourková Z; Schejbalová S; Cervenka L; Kramer HJ
    Kidney Blood Press Res; 2007; 30(1):38-44. PubMed ID: 17237618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.